Research shows it might significantly induce apoptosis and suppress proliferation in doxorubicin-resistant osteosarcoma cell lines via TUG1 mediated inhibition of Akt pathway in a concentration-dependent manner. The gene discussed is AKT1; the disease is osteosarcoma.